Home > Healthcare > Medical Devices > Implantable Devices > Coronary Stents Market

Coronary Stents Market Size

  • Report ID: GMI2966
  • Published Date: Nov 2024
  • Report Format: PDF

Coronary Stents Market Size

The global coronary stents market size was valued at USD 7.5 billion in 2024 and is expected to exhibit growth at a CAGR of 7.2% from 2025 to 2034. High market growth can be attributed to the rising prevalence of cardiovascular diseases, continuous advancements in stent technology, a growing geriatric population, and an increase in minimally invasive procedures, among other contributing factors.

 

Moreover, the rising prevalence of coronary artery disease (CAD), a primary cause of mortality globally, fuels the demand for coronary stents. For instance, according to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death worldwide, taking an estimated 17.9 million lives each year. Similarly, the Centers for Disease Control and Prevention (CDC) reports that approximately 18.2 million adults aged 20 and older in the U.S. have CAD. Factors such as inactive lifestyles, poor dietary habits, tobacco use, and aging populations contribute to the increase in cardiovascular disease cases, making stents an essential intervention for patients.
 

Furthermore, technological innovations, such as drug-eluting stents (DES), bioresorbable scaffolds, and polymer-free stents, improve patient outcomes by reducing the risks of restenosis and thrombosis. As these technologies continue to refine, patient and clinician confidence in stent efficacy grows, driving adoption.
 

Coronary stents are small, tube-like devices placed in narrowed or blocked coronary arteries to keep them open, improving blood flow to the heart. They are commonly used in patients with coronary artery disease to prevent heart attacks.
 

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global coronary stents industry was valued at USD 7.5 billion in 2024 and is expected to grow at a 7.2% CAGR from 2025 to 2034, driven by the rising prevalence of cardiovascular diseases.

The drug-eluting stent segment generated USD 6.4 billion in 2024 due to their ability to significantly reduce restenosis by releasing medication that prevents excessive tissue growth.

The North America coronary stents market recorded USD 3 billion in 2024 and is anticipated to grow at a 6.4% CAGR between 2025 and 2034, driven by a high incidence of cardiovascular diseases.

Key players in the industry include Abbott Laboratories, Andramed GmbH, B. Braun Melsungen, Biosensors International Group, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Medical, Elixir Medical Corporation, GENOSS, Medtronic, and Meril Life Science.

Coronary Stents Market Scope

Buy Now


Premium Report Details

  • Base Year: 2024
  • Companies covered: 15
  • Tables & Figures: 108
  • Countries covered: 19
  • Pages: 130
 Download Free Sample